e-learning
resources
Virtual 2021
06.09.2021
Bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
SYSTEMIC INFLAMMATION IN PATIENTS WITH STABLE NON-CYSTIC FIBROSIS BRONCHIECTASIS
L. Qin (Barcelona, Spain), M. Guitart (Barcelona, Spain), M. Alvarado-Miranda (Barcelona, Spain), X. Wang (Barcelona, Spain), E. Barreiro (Barcelona, Spain)
Source:
Virtual Congress 2021 – Bronchiectasis
Session:
Bronchiectasis
Session type:
E-poster
Number:
2074
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Qin (Barcelona, Spain), M. Guitart (Barcelona, Spain), M. Alvarado-Miranda (Barcelona, Spain), X. Wang (Barcelona, Spain), E. Barreiro (Barcelona, Spain). SYSTEMIC INFLAMMATION IN PATIENTS WITH STABLE NON-CYSTIC FIBROSIS BRONCHIECTASIS. 2074
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
PLEURO-PULMONARY COMPLICATIONS IN PATIENTS WITH CYSTIC FIBROSIS
Source: Virtual Congress 2020 – Cystic fibrosis
Year: 2020
PREVALENCE AND CHARACTERISTICS OF PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ADMITTED FOR PNEUMONIA ACQUIRED IN THE COMMUNITY.
Source: Virtual Congress 2020 – What is hot in idiopathic pulmonary fibrosis?
Year: 2020
LONG-TERM FOLLOW-UP OF PATIENTS WITH SYSTEMIC SCLEROSIS AND NORMAL OR BORDERLINE PULMONARY PRESSURES
Source: Virtual Congress 2020 – Epidemiology and treatment of pulmonary arterial hypertension
Year: 2020
PULMONARY HYPERTENSION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS ON ANTI-FIBROTIC TREATMENT WITH PIRFENIDONE OR NINTEDANIB: CLINICAL EVALUATION AND PROGNOSTIC IMPACT
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021
FOLLOW-UP OF PATIENTS WITH SEVERE COVID-19 PNEUMONIA AND TORPID EVOLUTION
Source: Virtual Congress 2021 – Translational and other aspects of idiopathic interstitial pneumonia
Year: 2021
ORAL MORPHINE IS SAFE IN SYMPTOMATIC PATIENTS WITH FIBROTIC INTERSTITIAL LUNG DISEASES
Source: International Congress 2019 – Treatment and prognosis of idiopathic interstitial pneumonia
Year: 2019
QUALITY OF LIFE OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND THEIR CAREGIVERS
Source: Virtual Congress 2020 – Organising respiratory disease management in primary care
Year: 2020
CORRELATION BETWEEN LUNG AND JOINT INVOLVEMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS AND INTERSTITIAL LUNG DISEASE: CROSS SECTIONAL STUDY
Source: International Congress 2018 – Clinical aspects of hypersensitivity pneumonitis (HP) and CTD-ILD: diagnosis, monitoring and treatment
Year: 2018
TEMPORAL RESOLUTION OF RIGHT VENTRICLE DYSFUNCTION IN PATIENTS WITH ACUTE SYMPTOMATIC PULMONARY EMBOLISM
Source: Virtual Congress 2020 – Epidemiology, diagnosis and management of pulmonary embolism
Year: 2020
A RESPIRATORY TELEREHABILITATION PROGRAM AS MAINTENANCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: International Congress 2018 – Let’s interact and discuss the hot topics in pulmonary rehabilitation
Year: 2018
SYSTEMIC EFFECT OF CONTINUOUS TREATMENT WITH AZITHROMYCYN IN PATIENTS WITH SEVERE COPD AND FREQUENT EXACERBATIONS
Source: International Congress 2019 – COPD clinical trials: new molecules and novel insights
Year: 2019
UTILITY OF THE HIGH FLOW WITH NASAL CANNULA IN THE DECANULATION OF TRAQUEOTOMIZED PATIENTS DURING AN EPISODE OF ACUTE RESPIRATORY INSUFFICIENCY.
Source: International Congress 2018 – New tools for managing respiratory failure
Year: 2018
ASSOCIATION OF EXERCISE CAPACITY AND ENDOTHELIAL FUNCTION IN PATIENTS WITH FIBROSING INTERSTITIAL LUNG DISEASE
Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease
Year: 2021
FUNCTIONAL AND METABOLIC CHARACTERISTICS OF BRONCHOALVEOLAR LAVAGE FLUID CELLS IN PATIENTS WITH PROLONGED COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2021 – Developments in biomarkers and treatment strategies for chronic lung diseases
Year: 2021
SURFACTANT THERAPY IN PATIENTS WITH SEVERE UNCONTROLLED BRONCHIAL ASTHMA
Source: International Congress 2018 – New modalities in asthma treatment
Year: 2018
CARDIOPULMONARY EXERCISE TESTING PREDICTING POSTOPERATIVE MORBIDITY IN PATIENTS WITH PULMONARY RESECTION
Source: Virtual Congress 2020 – Advances in lung function practice
Year: 2020
PLEURAL EFFUSION IN PATIENTS WITH COMMUNITY ACQUIRED PNEUMONIA
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
HEART VARIABILITY IN THE PRESENCE OF PSYCHOLOGICAL STRESS AND QUALITY OF LIFE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care
Year: 2020
DIAGNOSTICS, THERAPY, COURSE AND RESULTS IN PATIENTS WITH CHRONIC EXTRINSIC ALLERGIC ALVEOLITIS.
Source: Virtual Congress 2020 – Clinical aspects and new treatment strategies for rare interstitial lung diseases in adults and children
Year: 2020
EFFICACY OF IRON REPLETION WITHOUT ERYTHROPOIESIS-STIMULATING AGENT IN PATIENTS WITHCHEMOTHERAPY-INDUCED ANEMIA IN LUNG CANCER
Source: International Congress 2018 – Lung cancer: risk factors, supportive measures and quality improvement
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept